Key facts
- It has raised $14.2M; the latest was Early Stage VC ($14.2M) in Jan 2026.
- Notable investors include Capitallink, Henan Investment Group, Tsingke Biotech.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Zhongyuan Yuze
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhongyuan Yuze are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhongyuan Yuze
Manufacturer of bio-based materials designed to promote sustainable industrial development. The company offers advanced synthetic biology capabilities, including enzyme preparation and amino acid research and development, enabling agriculture, chemical, and feed sectors to implement eco-friendly processes with enhanced productivity.
- Sector
- Healthcare
- HQ
- Zhengzhou, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Zhongyuan Yuze doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhongyuan Yuze shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhongyuan Yuze in its N-PORT filings yet. We sweep new filings monthly.